Literature DB >> 16842187

Therapeutic modulation of growth factors and cytokines in regenerative medicine.

Effie Ioannidou1.   

Abstract

Regeneration that takes place in the human body is limited throughout life. Therefore, when organs are irreparably damaged, they are usually replaced with an artificial device or donor organ. The term "regenerative medicine" covers the restoration or replacement of cells, tissues, and organs. Stem cells play a major role in regenerative medicine by providing the way to repopulate organs damaged by disease. Stem cells have the ability to self renew and to regenerate cells of diverse lineages within the tissue in which they reside. Stem cells could originate from embryos or adult tissues. Growth factors are proteins that may act locally or systemically to affect the growth of cells in several ways. Various cell activities, including division, are influenced by growth factors. Cytokines are a family of low-molecular-weight proteins that are produced by numerous cell types and are responsible for regulating the immune response, inflammation, tissue remodeling and cellular differentiation. Target cells of growth factors and cytokines are mesenchymal, epithelial and endothelial cells. These molecules frequently have overlapping activities and can act in an autocrine or paracrine fashion. A complex network of growth factors and cytokines guides cellular differentiation and regeneration in all organs and tissues. The aim of this paper is to review the role of growth factors and cytokines in different organs or systems and explore their therapeutic application in regenerative medicine. The role of stem cells combined with growth factors and cytokines in the regeneration of vascular and hematopoietic, neural, skeletal, pancreatic, periodontal, and mucosal tissue is reviewed. There is evidence that supports the use of growth factors and cytokines in the treatment of neurological diseases, diabetes, cardiovascular disease, periodontal disease, cancer and its complication, oral mucositis. After solving the ethical issues and establishing clear and reasonable regulations, regenerative medicine through stem cell application combined with specific growth factors and cytokines will have great potential in curing a variety of human diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842187     DOI: 10.2174/138161206777699007

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  20 in total

1.  Soft tissue fibroblasts from well healing and chronic human wounds show different rates of myofibroblasts in vitro.

Authors:  Florian Schwarz; Martina Jennewein; Monika Bubel; Joerg H Holstein; Tim Pohlemann; Martin Oberringer
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

2.  The role of adipose-derived stem cells in a self-organizing 3D model with regard to human soft tissue healing.

Authors:  Martin Oberringer; Monika Bubel; Martina Jennewein; Silke Guthörl; Tamara Morsch; Sophie Bachmann; Wolfgang Metzger; Tim Pohlemann
Journal:  Mol Cell Biochem       Date:  2018-01-05       Impact factor: 3.396

3.  Increased and correlated expression of connective tissue growth factor and transforming growth factor beta 1 in surgically removed periodontal tissues with chronic periodontitis.

Authors:  T W Mize; K P Sundararaj; R S Leite; Y Huang
Journal:  J Periodontal Res       Date:  2014-07-09       Impact factor: 4.419

4.  Conditioned medium enhances the fusion capability of rat bone marrow mesenchymal stem cells and cardiomyocytes.

Authors:  Kanwal Haneef; Nadia Naeem; Irfan Khan; Hana'a Iqbal; Nurul Kabir; Siddiqua Jamall; Muniza Zahid; Asmat Salim
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

5.  The Effect of a Keratin Hydrogel Coating on Osseointegration: An Histological Comparison of Coated and Non-coated Dental Titanium Implants in an Ovine Model.

Authors:  Duncan I Campbell; Warwick J Duncan
Journal:  J Maxillofac Oral Surg       Date:  2013-02-01

Review 6.  Enabling stem cell therapies for tissue repair: current and future challenges.

Authors:  Victor W Wong; Michael Sorkin; Geoffrey C Gurtner
Journal:  Biotechnol Adv       Date:  2012-11-22       Impact factor: 14.227

7.  Designing biomaterials to direct stem cell fate.

Authors:  Chaenyung Cha; William B Liechty; Ali Khademhosseini; Nicholas A Peppas
Journal:  ACS Nano       Date:  2012-11-08       Impact factor: 15.881

8.  Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cells--implications for tissue regeneration.

Authors:  Chihwa Kim; Gabriela Schneider; Ahmed Abdel-Latif; Kasia Mierzejewska; Manjula Sunkara; Sylwia Borkowska; Janina Ratajczak; Andrew J Morris; Magda Kucia; Mariusz Z Ratajczak
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

9.  Development of bioartificial myocardium by electrostimulation of 3D collagen scaffolds seeded with stem cells.

Authors:  Kanwal Haneef; Nermine Lila; Samira Benadda; Fabien Legrand; Alain Carpentier; Juan C Chachques
Journal:  Heart Int       Date:  2012-09-18

10.  Evaluation of immediate and short-term efficacy of DualStim therapy with and without intracavernosal umbilical cord-derived Wharton's jelly in patients with erectile dysfunction: Study protocol for a randomized controlled trial.

Authors:  Ashim Gupta; Hugo C Rodriguez; Kristin Delfino; Howard J Levy; Saadiq F El-Amin; Richard Gaines
Journal:  Contemp Clin Trials Commun       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.